SEC Form 4 · accession 0000899243-16-028189
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Corwin Dale Hooks
Officer — See Remarks
Period of report
Aug 25, 2016
Accepted (ET)
Aug 29, 2016 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $22.73 | Aug 25, 2016 | A | 27,800 | A | — | Aug 25, 2026 | Common Stock | 27,800 | 27,800 | D |
| Restricted Stock UnitsF2,F3 | — | Aug 25, 2016 | A | 13,900 | A | — | — | Common Stock | 13,900 | 13,900 | D |
| Stock Option (right to buy)F4,F5 | $20.90 | holding | — | — | — | — | Feb 1, 2026 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (right to buy)F5,F6 | $19.37 | holding | — | — | — | — | Mar 1, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option shall vest as to 25% of the shares on August 25, 2017, and the remainder shall vest in substantially equal installments over the 36 months immediately following such date.
- F2Each restricted stock unit represents the right to receive one share of Common Stock.
- F3The restricted stock units shall vest as to 25% of the units on August 25, 2017, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date.
- F4The option shall vest as to 25% of the shares on February 1, 2017, and the remainder shall vest in substantially equal installments over the 36 months immediately following such date.
- F5The vesting schedule for this option was incorrectly reported on a previously filed Form 4. This Form 4 reflects the correct vesting schedule.
- F6The option shall vest as to 25% of the shares on March 1, 2017, and the remainder shall vest in substantially equal installments over the 36 months immediately following such date.
Remarks
Senior Vice President and Chief Commercial Officer